Nature’s Sunshine results
This article was originally published in The Tan Sheet
Executive Summary
Provo, Utah-based firm's net sales jumped 28.3% to $88.3 mil. with net earnings up 58.9% to $4.7 mil. in the fourth quarter; year-end sales advanced 27.3% to $331 mil. as net income more than tripled to $17.1 mil. Nature's Sunshine domestic sales grew 7.7% in the fourth-quarter and maintained "strong momentum" in its Synergy Worldwide business and international operations, CEO Douglas Faggioli says. Quarterly gain is attributable to new products, such as Thai-Go liquid supplements, and marketing initiatives including the Habit of Health 90-Day Challenge...
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.